Cannabis in the News, Research
Zelira Therapeutics Completes World’s First Clinical Trials for Treatment of Insomnia with Medical Cannabis Industry’s first clinically validated cannabinoid-based insomnia medication will launch globally PHILADELPHIA, April 7, 2020 /PRNewswire/...
Cannabis in the News, Research, Science, Technology/Innovations
Calyxt Licenses New Enabling Technology from University of Minnesota for Greater Efficiency in Gene-Edited Plants Unique Technology Has Potential to Reduce Gene-Edited Plant Production Timelines & Increase Speed to Market ROSEVILLE, Minn.–(BUSINESS...
Cannabis in the News, Cannabis Market, Featured, Hemp, Investment Opportunities, Research
Cannabis and Hemp Stocks: How do you Invest Now? Analysts predict the cannabis and hemp industry will surpass $75 billion dollars in less than a decade. The time to invest in cannabis and hemp is now. In fact, there’s never been a better time in history to start...
Cannabis in the News, CBD in the News, Finance, Financial Results, Hemp, Research, Science
Therapix Biosciences Ltd. Announces Shareholder Conference Call TEL AVIV, Israel, March 25, 2020 /PRNewswire/ — Therapix Biosciences Ltd. (Nasdaq: TRPX) (the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development...
Acquisition, Cannabis in the News, Finance, Health, Medical, Research, Science
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc. SAN DIEGO, March 24, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”),...
Cannabis in the News, Health, Hemp, Medical, Research, Science
InMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial VANCOUVER, March 24, 2020 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN;OTCQX:IMLFF), a clinical stage pharmaceutical...
